CHD6 promotes broad nucleosome eviction for transcriptional activation in prostate cancer cells. Issue 21 (21st November 2022)

• Record Type: Journal Article
• Authors: Zhao, Dongyu; Zhang, Min; Huang, Shaodong; Liu, Qi; Zhu, Sen; Li, Yanqiang; Jiang, Weihua; Kiss, Daniel L; Cao, Qi; Zhang, Lili; Chen, Kaifu
• Is Part Of: Nucleic acids research. Volume 50:Issue 21(2022)
• Page Start: 12186
• Page End: 12201
• Publication Date: 2022-11-21
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkac1090
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: Despite being a member of the chromodomain helicase DNA-binding protein family, little is known about the exact role of CHD6 in chromatin remodeling or cancer disease. Here we show that CHD6 binds to chromatin to promote broad nucleosome eviction for transcriptional activation of many cancer pathways. By integrating multiple patient cohorts for bioinformatics analysis of over a thousand prostate cancer datasets, we found CHD6 expression elevated in prostate cancer and associated with poor prognosis. Further comprehensive experiments demonstrated that CHD6 regulates oncogenicity of prostate cancer cells and tumor development in a murine xenograft model. ChIP-Seq for CHD6, along with MNase-Seq and RNA-Seq, revealed that CHD6 binds on chromatin to evict nucleosomes from promoters and gene bodies for transcriptional activation of oncogenic pathways. These results demonstrated a key function of CHD6 in evicting nucleosomes from chromatin for transcriptional activation of prostate cancer pathways.